Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00034915.xml
Onkologische Welt 2012; 03(02): 64-65
DOI: 10.1055/s-0038-1630932
DOI: 10.1055/s-0038-1630932
Gastro-Onkologie
Lebergerichtete Tumortherapie: Stellenwert der SIRT bei mNET und Cholangiokarzinom
Further Information
Publication History
Publication Date:
02 February 2018 (online)
Bei Lebermetastasen neuroendokriner Tumoren (mNET) gewinnt die SIRT (selektive interne Radiotherapie) unter den lebergerichteten Therapien zunehmend an Bedeutung. Experten diskutierten auf einem Europäischen Symposium in Paris über den Stellenwert der SIRT unter anderem in dieser Indikation und beim Cholangiokarzinom.
-
Literatur
- 1 Hoffmann RT. et al. Transarterial hepatic Yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: Factors associated with prolonged survival. Cardiovasc Intervent Radiol 2012; 35 (01) 105-116.
- 2 Ibrahim SM. et al. Treatment of unresectable cholangiocarcinoma using Yttrium-90 microspheres. Cancer 2008; 113 (08) 2119-2128.
- 3 Kennedy AS. et al. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microsperes: Early results in 148 patients. Am J Clin Oncol 2008; 31: 271-279.
- 4 King J. et al. Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases. Cancer 2008; 113: 921-929.
- 5 Saxena A. et al. Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: A preliminary assessment of this new treatment Option. Ann Surg Oncol 2010; 17 (02) 484-491.